Trial AMPlify Patient Recruitment Thought Leadership Blog

Plaque Psoriasis
By Jonathan Eilberg January 15, 2025
Trial AMPlify, a leader in clinical trial landing page design, launches a study site for Atossa Therapeutics to investigate a new psoriasis medication.
Clinical Trial Marketing
By Jonathan Eilberg December 22, 2024
Clinical trial marketing is critical for building awareness, trust and credibility when announcing and promoting studies, but most sponsors skip this step.
Advantages of a dedicated clinical trial website versus using clinicaltrials.gov
By Jonathan Eilberg October 18, 2024
Trial AMPlify explores the reasons why you should be using a dedicated clinical trial website versus your clinicaltrials.gov as the face of your study for patient recruitment. Learn more
Family of a clinical trial patient discussing a study
By Jon Eilberg April 28, 2024
Trial AMPlify makes the case that a clinical trial is a family decision and that it may involve a spouse, sibling, or parent who is opposed to joining a study.
Woman patient refusing to join a clinical trial
By Jonathan Eilberg December 16, 2023
Trial AMPlify examines why people refuse to join clinical trials and the critical role patient recruitment firms play in increasing enrollment. Learn more
Clinical Trial Manager
By Jonathan Eilberg December 4, 2023
Trial AMPlify examines why so many clinical trial patient recruitment campaigns fail and what can be done to help increase subject enrollment. Learn More
Patient Recruitment Agency
By Jonathan Eilberg November 20, 2023
Trial AMPlify helps define what a patient recruitment agency does and the ways it can help sponsors and CROs enroll qualified study subjects. Learn More
Clinical Trial Patient Recruitment Agency Team
November 14, 2023
Trial AMPlify presents a list of clinical trial patient recruitment terms for when a definition might escape you. Print the document for quick reference.
Patient recruitment online questionnaires do not work
By Jon Eilberg May 29, 2023
Trial AMPlify explains why forcing patients to take online surveys hinders the ability to attract subjects and can hurt the success of a study.
Patient Recruitment Website Traffic Graph
By Trial AMPlify May 5, 2023
Trial AMPlify, a leader in clinical trial patient recruitment makes a case to help biotech’s launch studies more quickly in these tough financial times.
Clinical Trial diversity and how we get there
By Jonathan Eilberg March 22, 2023
Trial AMPlify, a patient recruitment marketing agency based in Boston, relays ways US clinical trials can increase diverse patient enrollment.
Outsourcing Pharma Interview
February 23, 2023
Trial AMPlify is featured in latest issue of Outsourcing Pharma
Clinical Trial Abandonment
By Jonathan Eilberg February 22, 2023
Trial AMPlify explores the reason why some patients leave clinical trials prematurely, and how this affects the outcome of the study data. Learn More.
Clinical Trial Website SEO
By Jonathan Eilberg January 29, 2023
Trial AMPlify examines how to SEO your clinical trial website to perform better in search engines like Google and drive more patient enrollment. Learn More
Clinical Trial Patient Recruitment Diversity
By Jonathan Eilberg January 21, 2023
Trial AMPlify explores the importance of patient diversity within a clinical trial and the positive effects it has on the outcome. Click to learn more.
Clinical Trial Patient
By Jonathan Eilberg October 3, 2022
Trial AMPlify announces the launch of a new clinical trial patient recruitment campaign for an experimental breast cancer treatment called Evexomostat.
Patient Recruitment Clinical Trial Website
By Jonathan Eilberg September 12, 2022
Trial AMPlify examines what a great clinical trial website looks like when biotechs attempt to recruit new subjects and spread the word about their study.
Life Science website design and development best practices
By Jonathan Eilberg August 11, 2022
Trial AMPlify defines website design and development best practices to keep biotech and life science firms from malware attacks & having their site hacked.
Show More
Share by: